Fineline Cube

Follow:
14422 Articles
Auzone Submits NDA for Oral Edaravone TTYP01 to Treat ALS
CompanyDrug

Auzone Submits NDA for Oral Edaravone TTYP01 to Treat ALS

Pediatrix Therapeutics' Neffy NDA Accepted by NMPA for Allergy Treatment
CompanyDrug

Pediatrix Therapeutics’ Neffy NDA Accepted by NMPA for Allergy Treatment

Immunochina Pharmaceuticals and Cell Store Partner to Advance Cell Therapy Commercialization in China
CompanyDeals

Immunochina Pharmaceuticals and Cell Store Partner to Advance Cell Therapy Commercialization in China

Hinova Pharmaceuticals Enrolls First Patient in Phase II Study for HP518 in mCRPC
CompanyDrug

Hinova Pharmaceuticals Enrolls First Patient in Phase II Study for HP518 in mCRPC

Xbiome Partners with ZoHealth to Advance Microbiome Drug Development and Precision Nutrition
CompanyDeals

Xbiome Partners with ZoHealth to Advance Microbiome Drug Development and Precision Nutrition

Astellas Pharma Partners with Axcelead DDP for Targeted Protein Degraders Discovery
CompanyDeals

Astellas Pharma Partners with Axcelead DDP for Targeted Protein Degraders Discovery

AusperBio Secures $73 Million in Series B Financing to Advance Hepatitis B Therapy
CompanyDeals

AusperBio Secures $73 Million in Series B Financing to Advance Hepatitis B Therapy

Advaccine Biotechnology's MICROEPAD Receives FDA Registration Approval
CompanyDrug

Advaccine Biotechnology’s MICROEPAD Receives FDA Registration Approval

Shandong Buchang Pharmaceuticals Terminates Agreement with NOVAST Laboratories
CompanyDeals

Shandong Buchang Pharmaceuticals Terminates Agreement with NOVAST Laboratories

Chia Tai Tianqing's Benmelstobart and Anlotinib Combo Meets Primary Endpoint in Phase III Study
CompanyDrug

Chia Tai Tianqing’s Benmelstobart and Anlotinib Combo Meets Primary Endpoint in Phase III Study

Chia Tai Tianqing's Benmelstobart and Anlotinib Combo Meets Primary Endpoint in Phase III Study
CompanyDrug

China Isotope & Radiation Corporation’s [18F] Piramide Receives NMPA Clinical Trial Approval

Hybio Pharmaceutical Receives US FDA Approval for Biosimilar Victoza (Liraglutide)
CompanyDrug

Hybio Pharmaceutical Receives US FDA Approval for Biosimilar Victoza (Liraglutide)